Philippine Standard time

Preparing for shortages of future Covid-19 drugs: A data-based model for optimal allocation.

DLSU-AKI Policy Brief, Volume XIII, No. 1.
2020

Future approved COVID-19 drugs will be short in supply until global production capacity is built up to meet demand. It is necessary for health administrators to exercise sound judgement in allocating a very scarce resource.

Citations

This publication has been cited time(s).


Related Publications

Cultivating Constructive Civic Emotions: Why Compassion Matters in Human Survival During the COVID19 Pandemic

PUP
MabRev2019-05
2019
0 Downloads

Estimating the Effects of the Trump Tariff on Philippine Exports: A Policy Brief

DLSU - AKI
DLSU-AKI Policy, 2025-04-053
2025
31 Downloads

Sovereign Debt Vulnerabilities: Assessing the Philippines’ Fiscal Risks and Future Outlook

CPBRD
DP2025-08:
2025
3 Downloads
Contributor
DLSU - Angelo King Institute for Economic and Business Studies
Authors
Torneo, Ador, R.
Keywords
Cite
Downloads

47

Since
Jul 24, 2020

More Publications from DLSU - Angelo King Institute for Economic and Business Studies
An ASEAN digital single market: Boosting the aspiration for a single market in the digital era.
2019
846 DOWNLOADS
Determinants of Entrepreneurial Venture Growth in the Philippines Using the Global Entrepreneurship Monitor
2021
833 DOWNLOADS
The Relationship between Stock Return Volatility and Trading Volume: The Case of the Philippines
2008
504 DOWNLOADS
Assessing the Potential Impacts of Reducing Philippine Corporate Income Tax and Reforming Sectoral Incentives on Poverty and Employment
2020
472 DOWNLOADS
General Asymmetric Stochastic Volatility Models Using Range Data: Estimation and Empirical Evidence from Emerging Equity Markets
2010
427 DOWNLOADS
View More Publications